Answers are grounded in this paper and cite their sources.
Dear Editor, Several studies among men with end-stage renal disease have estimated the prevalence of erectile dysfunction (ED) to range from 41.5% to 82%.1-3 The aetiology of ED in men with chronic kidney disease (CKD) is multifactorial. As such, ED represents the sequel of the complex neuroendocrine and metabolic changes typical of uraemic syndrome.3,4 In addition, pharmacological therapy for uraemia and the attendant physical and psychological stress may also play an important role in the genesis of this problem.5 This study aimed to assess the prevalence of sexual dysfunction, to identify the correlates of social, psychological, behavioural and metabolic factors, and to assess the extent of risk of comorbid cardiovascular and metabolic factors associated with the occurrence of ED in these male uraemic patients.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: